BRPI0910740A2 - sistema terapêutico transdérmico para a administração de fentanila ou um análogo da mesma - Google Patents

sistema terapêutico transdérmico para a administração de fentanila ou um análogo da mesma

Info

Publication number
BRPI0910740A2
BRPI0910740A2 BRPI0910740A BRPI0910740A BRPI0910740A2 BR PI0910740 A2 BRPI0910740 A2 BR PI0910740A2 BR PI0910740 A BRPI0910740 A BR PI0910740A BR PI0910740 A BRPI0910740 A BR PI0910740A BR PI0910740 A2 BRPI0910740 A2 BR PI0910740A2
Authority
BR
Brazil
Prior art keywords
fentanyl
analogue
administration
therapeutic system
transdermal therapeutic
Prior art date
Application number
BRPI0910740A
Other languages
English (en)
Inventor
Ingo Teutsch
Nouha Salman
Original Assignee
Acino Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acino Ag filed Critical Acino Ag
Publication of BRPI0910740A2 publication Critical patent/BRPI0910740A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0910740A 2008-04-25 2009-04-24 sistema terapêutico transdérmico para a administração de fentanila ou um análogo da mesma BRPI0910740A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08155167A EP2111857A1 (de) 2008-04-25 2008-04-25 Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
PCT/EP2009/003010 WO2009130039A1 (de) 2008-04-25 2009-04-24 Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff hiervon

Publications (1)

Publication Number Publication Date
BRPI0910740A2 true BRPI0910740A2 (pt) 2015-09-29

Family

ID=39730747

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910740A BRPI0910740A2 (pt) 2008-04-25 2009-04-24 sistema terapêutico transdérmico para a administração de fentanila ou um análogo da mesma

Country Status (9)

Country Link
US (1) US20110111013A1 (pt)
EP (2) EP2111857A1 (pt)
JP (1) JP2011518795A (pt)
CN (1) CN102014884A (pt)
AU (1) AU2009240195B2 (pt)
BR (1) BRPI0910740A2 (pt)
CA (1) CA2721013A1 (pt)
MX (1) MX2010011196A (pt)
WO (1) WO2009130039A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011100619A1 (de) 2010-05-05 2012-01-05 Amw Gmbh Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum
EP2599478A1 (de) 2011-11-30 2013-06-05 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
US9072682B2 (en) 2012-12-31 2015-07-07 Mylan Inc. Transdermal dosage form for low-melting point active agent
US20180271800A1 (en) 2017-03-24 2018-09-27 E Ink California, Llc Microcell systems for delivering active molecules
DE102014000200A1 (de) * 2014-01-03 2015-07-09 Michael Horstmann Transdermales Therapeutisches System
CN104758181A (zh) * 2015-04-09 2015-07-08 史祎 一种无溶剂贴敷剂制备工艺
US11541018B2 (en) 2016-06-23 2023-01-03 Corium, Llc Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
JP7251033B2 (ja) * 2016-07-27 2023-04-04 コリウム， エルエルシー ドネペジル経皮送達システム
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
US10646454B2 (en) 2017-03-24 2020-05-12 E Ink California, Llc Microcell delivery systems including charged or magnetic particles for regulating rate of administration of actives
JP7175913B2 (ja) 2017-04-18 2022-11-21 ブレイクスルー・テクノロジーズ・エルエルシー 硫黄生成
EP3612170A4 (en) * 2017-04-19 2021-01-27 Inep Europe Sarl PROCESS FOR MANUFACTURING A TRANSDERMAL FENTANYPE PLASTER WITH EVEN DISTRIBUTION OF MEDICINAL CRYSTALS
JP6972334B2 (ja) 2017-11-14 2021-11-24 イー インク カリフォルニア， エルエルシー 多孔性伝導電極層を含む電気泳動活性分子送達システム
CN110693857B (zh) * 2019-10-17 2023-08-11 宜昌人福药业有限责任公司 一种舒芬太尼透皮贴剂及其制备方法
KR20220074962A (ko) 2019-11-27 2022-06-03 이 잉크 캘리포니아 엘엘씨 전기 침식 밀봉층을 갖는 마이크로셀들을 포함하는 유익제 전달 시스템
WO2022093547A1 (en) 2020-10-29 2022-05-05 E Ink California, Llc Microcell systems for delivering hydrophilic active molecules
CN116322881A (zh) 2020-10-29 2023-06-23 伊英克加利福尼亚有限责任公司 用于递送有益剂的微单元系统

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2079194B (en) * 1980-07-09 1983-08-03 Westering Insulation Systems L Coil shaping apparatus
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4588560A (en) 1984-06-29 1986-05-13 Mobil Oil Corporation Hydroprocessing reactor for catalytically dewaxing liquid petroleum feedstocks
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE19546024C2 (de) * 1995-12-09 1998-09-10 Lohmann Therapie Syst Lts Transdermale pharmazeutische Zubereitung und deren Herstellung
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
DE19830898A1 (de) 1998-07-10 2000-01-13 Hexal Ag Vorrichtung zur Verbesserung der Entnahmefähigkeit von in Beuteln verpackten, haftklebend ausgerüsteten, flächigen Substratabschnitten
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
EP1280485A4 (en) * 2000-02-29 2006-11-29 Zars Inc TRANSDERMAL STAMP FOR IMPROVED MEDICINE
WO2002074286A1 (en) 2001-03-16 2002-09-26 Alza Corporation Transdermal patch for administering fentanyl
JP2002332228A (ja) * 2001-05-11 2002-11-22 Yuutoku Yakuhin Kogyo Kk 経皮吸収貼付剤およびその製造方法
JP4758101B2 (ja) 2002-09-13 2011-08-24 久光製薬株式会社 貼付剤
TWI296531B (en) 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
ES2315600T3 (es) 2004-08-09 2009-04-01 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Conjugados de albumina que contienen un ligador glucuronico.
WO2006047362A2 (en) * 2004-10-21 2006-05-04 Durect Corporation Transdermal delivery systems

Also Published As

Publication number Publication date
EP2265264A1 (de) 2010-12-29
WO2009130039A1 (de) 2009-10-29
AU2009240195A1 (en) 2009-10-29
CA2721013A1 (en) 2009-10-29
MX2010011196A (es) 2010-12-15
AU2009240195B2 (en) 2013-09-12
CN102014884A (zh) 2011-04-13
JP2011518795A (ja) 2011-06-30
US20110111013A1 (en) 2011-05-12
EP2111857A1 (de) 2009-10-28

Similar Documents

Publication Publication Date Title
BRPI0910740A2 (pt) sistema terapêutico transdérmico para a administração de fentanila ou um análogo da mesma
BR112012005629A2 (pt) sistema terapêutico transdérmico para administrar fentanila ou um análogo da mesma
DK2274032T3 (da) Anordning til medicinindgivelse
BRPI0913214A2 (pt) sistema de fornecimento de drogas transdérmico estabilizado
DK2073860T3 (da) Lægemiddelfrigivende coatinger til medicinske indretninger
BR112013014616A2 (pt) sistema terapêutico transdérmico para a administração de uma substância ativa
SMT201500232B (it) Dispositivo per la somministrazione de farmaci
PT2515886T (pt) Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivados
DK2117521T3 (da) Transdermale indgivelsessystemer omfattende bupivacain
BRPI0819245A2 (pt) sistema de distribuição transdérmica
BRPI1009324A2 (pt) compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
DK2173407T3 (da) Anordning til indgivelse af lægemiddel
DK2445570T3 (da) Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling
DK1983964T3 (da) Anordning til indgivelse af lægemiddel
DK2185220T3 (da) Anordning til lægemiddelfremføring
BRPI0916877A2 (pt) composição farmacêutica e administração da mesma
DK2381988T3 (da) Medikamentadministrationsanordning
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
BRPI0917030A2 (pt) sistema de liberação de fármaco contendo progestina
BRPI0909653A2 (pt) sistema terapêutico transdérmico com membrama estabilizada
DK2010190T3 (da) Farmaceutisk opløsningsformulering til tryksatte, dosisregulerede inhalatorer
BRPI0817075A2 (pt) núcleos de fármaco para liberação prolongada de agentes terapêuticos
BRPI0908231A2 (pt) Sistema de liberação de fármaco com efeito estabilizante
BRPI1006948A2 (pt) sistema de identificação de medicamento para dispositivos de injeção de doses múltiplas
BRPI1009252A2 (pt) composto, pró-droga, composição farmacêutica, métodos para prevenir ou tratar doenças do sistema nervoso central, e mal de alzheimer, e, uso do composto ou de uma pró-droga do mesmo

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.